2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow diroximel fumarate: new trials by email Literature Review of diroximel fumarate trials Research Report on diroximel fumarate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Diroximel Fumarate (DRF) in Chinese and Caucasian Adult Healthy Participants Diroximel fumarate - Healthy Volunteers | Phase 1 | Completed | Biogen | 32 | 2021-12-03 | 2022-07-05 |
| Bioequivalence Study of Bafiertam 190 mg and Vumerity® 462 mg Delayed-Release Capsules in Fasting Healthy Subjects Monomethyl Fumarate 190 Mg, Diroximel Fumarate 462 mg - Relapsing Remitting Multiple Sclerosis | Phase 1 | Completed | Banner Life Sciences LLC | 46 | 2021-05-14 | 2022-01-06 |
Multiple Sclerosis, Relapsing-Remitting (1)
Banner Life Sciences LLC (1) · Biogen (1)
Hong Kong (1) · New Zealand (1) · United States (1)